American Heart Association Consortium Advances Development of Evidence-Based Health Tech Solutions
CHICAGO and OXFORD, England, Oct. 31, 2025 /PRNewswire/ — In a significant move towards harnessing technology for improved health outcomes, Brainomix, a trailblazer in AI-powered medical imaging, has joined forces with the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. This partnership is aimed at propelling innovation and transforming healthcare by fostering relationships among various stakeholders in health technology.
The Innovators’ Network serves as a pivotal consortium that connects entrepreneurs, healthcare providers, researchers, and payers. The primary goal is to drive advancements in cardiovascular and brain health. For members, this platform offers unparalleled access to the American Heart Association’s digital scientific guidelines and clinical recommendations, which are essential for developing evidence-based digital healthcare technologies. By collaborating with the Center, members can also embark on designing models for clinical outcome studies. This collaboration not only reduces the costs associated with independent studies but also bridges the gap between scientific research and practical technology applications. Fueled by evidence, it aims to enhance healthcare outcomes, which remains a significant concern for healthcare providers and payers alike.
“The Center aims to advance the rapid, efficient, and effective development of healthcare technology,” stated Dr. Robert A. Harrington, a prominent figure in this initiative. With his extensive experience as the volunteer past president of the American Heart Association and his current roles as chair of the Health Tech Advisory Group and dean of Weill Cornell Medicine, Dr. Harrington emphasizes the importance of leveraging the consortium. He encourages members to broaden their engagement in health tech, fostering an environment where innovation can flourish.
Brainomix’s involvement is particularly noteworthy. Michalis Papadakis, the company’s CEO and co-founder, shared his enthusiasm for joining the Innovators’ Network. He highlighted that Brainomix stands out as the only AI-focused company specializing in stroke technology within this consortium. Papadakis expressed optimism about collaborating with the American Heart Association to integrate AI more deeply into stroke assessment processes. The company aims to enhance clinical decision-making throughout the patient care journey, ensuring that clinicians can make informed, impactful treatment decisions. This approach aligns closely with the overarching goal of improving patient outcomes.
At the heart of Brainomix’s innovation is its flagship product, Brainomix 360 Stroke. This platform is heralded as the world’s first fully automated AI-imaging system, designed specifically for acute stroke assessment. Its capabilities enable healthcare professionals to make confident treatment and transfer decisions, irrespective of existing local resources or peer expertise. Alongside this, Brainomix 360 e-Lung technology utilizes AI-driven CT biomarkers to monitor and predict disease progression in pulmonary fibrosis, showcasing the company’s commitment to precision medicine.
Founded as a spinout from the University of Oxford, Brainomix has carved out a global presence, operating in over 20 countries, including offices in the UK, Ireland, and the USA. Their dedication to utilizing AI in healthcare aims to refine treatment pathways, ultimately leading to better patient care.
For those interested in exploring more about the innovative contributions of Brainomix and its technology, further information can be found on their official website at www.brainomix.com. They are also active on social media platforms like Twitter, LinkedIn, and Facebook.
Contacts
For further inquiries, Jeff Wyrtzen serves as the Chief Marketing Officer and can be reached at jeff.wyrtzen@brainomix.com. Alternatively, US media inquiries can be directed to Jason Braco, Ph.D., at LifeSci Communications, reachable via email at jason.braco@lifescicommunications.com. For UK and Europe media, Sue Charles at Charles Consultants can be contacted at sue.charles@charlesconsultants.com.
Logo: https://mma.prnewswire.com/media/1989193/5592565/Brainomix_Logo.jpg
